India AI Assisted Radiology Market

ID: MRFR/HC/63967-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
India AI Assisted Radiology Market Research Report By Technique (X-rays, Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Others), By Application (Neurology, Mammography, Cardiovascular, Respiratory and Pulmonary, Orthopedics, Others) and By End User (Hospitals, Diagnostic Imaging Centers, Others) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India AI Assisted Radiology Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)32.19%
2024 Market Size$ 65 Million
2025 Market Size$ 85.92 Million
2035 Market Size$ 1,400 Million

Key Players

Siemens Healthineers
GE Healthcare
Philips Healthcare
IBM Watson Health
Aidoc
Zebra Medical Vision
Opportunities
  • Growing Aging Population
  • Increasing Healthcare Expenditure
  • Government Initiatives and Funding
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Life Sciences, BY Technique (USD Million)
      1. 4.1.1 X-Rays
      2. 4.1.2 Magnetic Resonance Imaging
      3. 4.1.3 Computed Tomography
      4. 4.1.4 Positron Emission Tomography
      5. 4.1.5 Others
    2. 4.2 Life Sciences, BY Application (USD Million)
      1. 4.2.1 Neurology
      2. 4.2.2 Mammography (Breast Cancer)
      3. 4.2.3 Cardiovascular
      4. 4.2.4 Respiratory and Pulmonary
      5. 4.2.5 Orthopedics
      6. 4.2.6 Others
    3. 4.3 Life Sciences, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Diagnostic Imaging Centers
      3. 4.3.3 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Life Sciences
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Siemens Healthineers (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 GE Healthcare (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Philips Healthcare (NL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 IBM Watson Health (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Aidoc (IL)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Zebra Medical Vision (IL)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Arterys (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Qure.ai (IN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY TECHNIQUE
    3. 6.3 INDIA MARKET ANALYSIS BY APPLICATION
    4. 6.4 INDIA MARKET ANALYSIS BY END USER
    5. 6.5 KEY BUYING CRITERIA OF LIFE SCIENCES
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF LIFE SCIENCES
    8. 6.8 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
    10. 6.10 SUPPLY / VALUE CHAIN: LIFE SCIENCES
    11. 6.11 LIFE SCIENCES, BY TECHNIQUE, 2024 (% SHARE)
    12. 6.12 LIFE SCIENCES, BY TECHNIQUE, 2024 TO 2035 (USD Million)
    13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
    16. 6.16 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TECHNIQUE, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India Life Sciences Market Segmentation

Life Sciences By Technique (USD Million, 2025-2035)

  • X-Rays
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Positron Emission Tomography
  • Others

Life Sciences By Application (USD Million, 2025-2035)

  • Neurology
  • Mammography (Breast Cancer)
  • Cardiovascular
  • Respiratory and Pulmonary
  • Orthopedics
  • Others

Life Sciences By End User (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Imaging Centers
  • Others